CLSA Statement on Passage of California State Budget
Sacramento, CA (June 26, 2020) — California Life Sciences Association president and CEO Mike Guerra issued the following statement on the passage of the California state budget:
“The current state budget includes a number of provisions that will have a detrimental impact on innovation, slowing the treatment, testing, and search for a cure to the COVID19 pandemic while potentially leading the state into further economic decline.
The provisions of the budget eliminating research and development credits, implementing international reference pricing (foreign price controls) to drug purchasing, and applying Medicaid rebates to non-Medicaid populations will negatively impact patient choice and access to medicines while impairing the development of new treatments for unmet medical needs.
Our association represents the second largest technical employer base in California and is intrinsic to the science behind how we, as a country and global economic partner, come through this crisis.
Californians want healthcare to be less expensive, but also want it to be the most innovative in the world. The key to simultaneously achieving both of these goals is good public policy, and this budget misses the mark. We cannot afford to short-circuit life-saving innovation occurring in California’s world-leading biomedical sector.
On behalf of California’s life sciences innovators, a sector with more than 3,400 firms employing almost 1 million Californians, CLSA stands ready to work with our state government on legislation that will support California’s continued leadership in life sciences innovation, and meaningfully deliver affordable, accessible, and innovative therapies for patients who need them.”
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State.
California Life Sciences Association (CLSA)
Oliver Rocroi | Vice President, Communications and External Affairs
firstname.lastname@example.org | 916-588-0965